Evaluation of health utility in trial-based cost–utility analyses for major cardiovascular disease: protocol for a systematic review

INTRODUCTION: The global incidence of cardiovascular disease (CVD) is high, and the medical costs associated with its management have been increasing. Cost–utility analyses (CUAs) are essential for understanding the value of healthcare interventions and for decision-making. A majority of the CUAs fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Yasuhisa, Kawakami, Hiroshi, Miyazaki, Shigehiro, Saito, Makoto, Luo, Yan, Yamamoto, Kazumichi, Yamaguchi, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173991/
https://www.ncbi.nlm.nih.gov/pubmed/37160387
http://dx.doi.org/10.1136/bmjopen-2022-067045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173991/
https://www.ncbi.nlm.nih.gov/pubmed/37160387
http://dx.doi.org/10.1136/bmjopen-2022-067045

Ejemplares similares